# A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity

> **NCT07731139** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 120 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Placebo
- **DRUG:** PF-08642534

## Key facts

- **NCT ID:** NCT07731139
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-28
- **Primary completion:** 2027-04-21
- **Final completion:** 2027-04-21
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07731139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07731139, "A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity". Retrieved via MORVS 2026-10-24 from https://api.morvs.ai/clinical/NCT07731139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*